论文部分内容阅读
Objective Although endocrine therapy using estrogen antagonist tamoxifen can effectively improve the survival rate of estrogen receptor-alpha(ERa)positive breast cancers,it has been demonstrated that a large proportion of patients are resistant to tamoxifen therapy.